DE69910242D1 - Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen - Google Patents
Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von ZwangsneurosenInfo
- Publication number
- DE69910242D1 DE69910242D1 DE69910242T DE69910242T DE69910242D1 DE 69910242 D1 DE69910242 D1 DE 69910242D1 DE 69910242 T DE69910242 T DE 69910242T DE 69910242 T DE69910242 T DE 69910242T DE 69910242 D1 DE69910242 D1 DE 69910242D1
- Authority
- DE
- Germany
- Prior art keywords
- compulsive disorder
- obsessive compulsive
- treatment
- receptor agonist
- nicotine receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803732 | 1998-11-02 | ||
| SE9803732A SE9803732D0 (sv) | 1998-11-02 | 1998-11-02 | Nicotine treatment for obsessive compulsive disorder |
| PCT/SE1999/001948 WO2000025783A1 (en) | 1998-11-02 | 1999-10-29 | Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69910242D1 true DE69910242D1 (de) | 2003-09-11 |
| DE69910242T2 DE69910242T2 (de) | 2004-06-17 |
Family
ID=20413142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69910242T Expired - Fee Related DE69910242T2 (de) | 1998-11-02 | 1999-10-29 | Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1126846B1 (de) |
| JP (1) | JP2002528501A (de) |
| AT (1) | ATE246503T1 (de) |
| AU (1) | AU1514700A (de) |
| CA (1) | CA2347855A1 (de) |
| DE (1) | DE69910242T2 (de) |
| DK (1) | DK1126846T3 (de) |
| ES (1) | ES2203210T3 (de) |
| NZ (1) | NZ511226A (de) |
| PT (1) | PT1126846E (de) |
| SE (1) | SE9803732D0 (de) |
| WO (1) | WO2000025783A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| AU9543601A (en) | 2000-10-13 | 2002-04-22 | Neurosearch As | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| DE20018196U1 (de) | 2000-10-25 | 2001-01-11 | Peter, Michael N., 22297 Hamburg | Erzeugnis aus Zuckerware für Raucherentwöhnung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776956A (en) * | 1996-07-30 | 1998-07-07 | Lectec Corporation | Use of cotinine in treating psychiatric disorders |
-
1998
- 1998-11-02 SE SE9803732A patent/SE9803732D0/xx unknown
-
1999
- 1999-10-29 ES ES99957446T patent/ES2203210T3/es not_active Expired - Lifetime
- 1999-10-29 EP EP99957446A patent/EP1126846B1/de not_active Expired - Lifetime
- 1999-10-29 DE DE69910242T patent/DE69910242T2/de not_active Expired - Fee Related
- 1999-10-29 AU AU15147/00A patent/AU1514700A/en not_active Abandoned
- 1999-10-29 PT PT99957446T patent/PT1126846E/pt unknown
- 1999-10-29 JP JP2000579224A patent/JP2002528501A/ja not_active Withdrawn
- 1999-10-29 CA CA002347855A patent/CA2347855A1/en not_active Abandoned
- 1999-10-29 NZ NZ511226A patent/NZ511226A/xx unknown
- 1999-10-29 AT AT99957446T patent/ATE246503T1/de not_active IP Right Cessation
- 1999-10-29 WO PCT/SE1999/001948 patent/WO2000025783A1/en active IP Right Grant
- 1999-10-29 DK DK99957446T patent/DK1126846T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1126846B1 (de) | 2003-08-06 |
| DK1126846T3 (da) | 2003-09-29 |
| WO2000025783A1 (en) | 2000-05-11 |
| ES2203210T3 (es) | 2004-04-01 |
| PT1126846E (pt) | 2003-12-31 |
| NZ511226A (en) | 2003-01-31 |
| EP1126846A1 (de) | 2001-08-29 |
| JP2002528501A (ja) | 2002-09-03 |
| CA2347855A1 (en) | 2000-05-11 |
| AU1514700A (en) | 2000-05-22 |
| ATE246503T1 (de) | 2003-08-15 |
| SE9803732D0 (sv) | 1998-11-02 |
| DE69910242T2 (de) | 2004-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001001973A3 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| IL151164A0 (en) | Azacyclic compounds for use in the treatment of serotonin related diseases | |
| DE602006021444D1 (de) | Therapie zur behandlung der überaktiven blase | |
| ATE207352T1 (de) | Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen | |
| DE60218193D1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
| ATE301462T1 (de) | Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden | |
| DE60123117D1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs | |
| DE69910242D1 (de) | Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen | |
| SE9902597D0 (sv) | New use | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| SE0102887D0 (sv) | New formulation | |
| NO20005131L (no) | Nye behandlinger for nervøse forstyrrelser | |
| SE9904424D0 (sv) | Use of interleukin-6 in combination with leptin in treatment of obesity | |
| EP1632235A3 (de) | Verwendung von hochselektiven Norepinephrin-Aufnahme-Inhibitoren zur Behandlung von mentalen Erkrankungen | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
| DE60222662D1 (de) | Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung | |
| DE69923698D1 (de) | Verwendung von 3-(1h-imidazol-4-ylmethyl)-indan-5-ol zur herstellung eines medikamentes zur intraspinalen, intrathekalen und epiduralen anwendung | |
| ATE345124T1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia | |
| ATE296640T1 (de) | Methode und mittel zur behandlung eines post- poliosyndroms | |
| TR200100670T2 (tr) | R(+)-alfa-(2,3-Dimetoksifenil)-1- [2-(4-florofenil)etil]-4-piperidinmetanol' ün uyku düzensizlikleri tedavisinde kullanımı. | |
| CA2532330A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| RU2001102089A (ru) | Способ лечения дисциркуляторной энцефалопатии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |